Mar. 20 at 7:26 PM
MFN drug pricing is moving from executive order to legislation — and Big Pharma is now at the table. ⚠️
$JNJ holding
$237.60, sitting between SMA50 (
$233.58) and SMA20 (
$243.07), RSI 45. Relative strength vs peers.
$LLY at
$917.50 — down 14.63% YTD, RSI 32, still below both key MAs.
$NVO is the wreckage: -27.12% YTD, RSI 31.82, near 52-week low of
$35.85.
Codifying MFN = structural margin pressure. Watch
$JNJ SMA20 as resistance.
$LLY and
$NVO look like falling knives until legislative clarity arrives.
#Pharma #DrugPricing #Biotech
